Serum Osteocalcin As a Diagnostic Biomarker for Primary Osteoporosis in Women

Overview

Journal J Clin Diagn Res

Specialty General Medicine

Date 2015 Oct 6

PMID 26436008

Citations 41

Authors

Sudhir Singh

Dharmendra Kumar

Atil Kumar Lal

Affiliations

Soon will be listed here.

Abstract

Introduction: Osteoporosis, a major health problem in elderly population, especially in post-menopausal females, is diagnosed basically on clinical suspicion and bone mineral density measurement. Dual energy x-ray absorptiometry (DEXA) scan though a gold standard of diagnosis becomes unfit for screening purpose due to its prohibitive cost, unportability and lack of availability of machine.

Aim: To assess the diagnostic potential of serum osteocalcin levels in primary osteoporosis.

Materials And Methods: In a case-control study, 82 post-menopausal females, between 40-70 years, were subjected to measurements of bone mineral density and serum osteocalcin levels. Based on the results of DEXA scan they were divided into two: a) Control group and B) Case group. Case group was further subdivided as Osteopenia and Osteoporosis depending on their t-scores. Correlation between different BMD grades and the levels of serum osteocalcin were analysed statistically.

Results: A negative correlation was found between serum osteocalcin levels and BMD grading. Significant association of age and years since menopause (YSM) was found with serum osteocalcin levels and BMD. No association of BMI and serum osteocalcin was observed with BMD. Statistically significant difference between values of serum osteocalcin in postmenopausal non-osteoporotic women, post-menopausal women with low bone mass (osteopenia) and post-menopausal women with osteoporosis were seen.

Conclusion: Serum osteocalcin level measurement can be used for screening purpose in post-menopausal patients. Subjects can be further assessed by DEXA scan to, if indicated.

Citing Articles

Unraveling the impact of blood RANKL and OPG levels on Alzheimer's disease: Independent of bone mineral density and inflammation.

Guo X, Shi W, Lu J, Tang P, Li R Alzheimers Dement (N Y). 2025; 11(1):e70044.

PMID: 39839077 PMC: 11746068. DOI: 10.1002/trc2.70044.

The antiosteoporotic effect of oxymatrine compared to testosterone in orchiectomized rats.

Shaban A, Ali E, Tayel S, Rizk S, El Agamy D J Orthop Surg Res. 2025; 20(1):25.

PMID: 39780225 PMC: 11714950. DOI: 10.1186/s13018-024-05344-0.

The Role of Osteocalcin in Patients with Osteoporosis: A Systematic Review.

Mohammadi S, Saniee N, Mousaviasl S, Radmanesh E, Doustimotlagh A Iran J Public Health. 2024; 53(11):2432-2439.

PMID: 39619893 PMC: 11607154. DOI: 10.18502/ijph.v53i11.16945.

In vivo glycation-interplay between oxidant and carbonyl stress in bone.

Sroga G, Vashishth D JBMR Plus. 2024; 8(11):ziae110.

PMID: 39386996 PMC: 11458925. DOI: 10.1093/jbmrpl/ziae110.

Proteomic Biomarkers Associated with Low Bone Mineral Density: A Systematic Review.

Becerra-Cervera A, Argoty-Pantoja A, Aparicio-Bautista D, Lopez-Montoya P, Rivera-Paredez B, Hidalgo-Bravo A Int J Mol Sci. 2024; 25(14).

PMID: 39062769 PMC: 11277462. DOI: 10.3390/ijms25147526.

References

Ahlborg H, Johnell O, Turner C, Rannevik G, Karlsson M . Bone loss and bone size after menopause. N Engl J Med. 2003; 349(4):327-34. DOI: 10.1056/NEJMoa022464. View

Fawzy T, Muttappallymyalil J, Sreedharan J, Ahmed A, Alshamsi S, Al Ali M . Association between Body Mass Index and Bone Mineral Density in Patients Referred for Dual-Energy X-Ray Absorptiometry Scan in Ajman, UAE. J Osteoporos. 2011; 2011:876309. PMC: 3135277. DOI: 10.4061/2011/876309. View

van der Voort D, Geusens P, Dinant G . Risk factors for osteoporosis related to their outcome: fractures. Osteoporos Int. 2001; 12(8):630-8. DOI: 10.1007/s001980170062. View

Civitelli R, Armamento-Villareal R, Napoli N . Bone turnover markers: understanding their value in clinical trials and clinical practice. Osteoporos Int. 2009; 20(6):843-51. DOI: 10.1007/s00198-009-0838-9. View

Filip R, Zagorski J . Age- and BMD-related differences in biochemical markers of bone metabolism in rural and urban women from Lublin Region, Poland. Ann Agric Environ Med. 2005; 11(2):255-9. View

Del Pino J, Cordero M, Lanchares J, Garcia-Talavera J . Influence of sex, age, and menopause in serum osteocalcin (BGP) levels. Klin Wochenschr. 1990; 69(24):1135-8. DOI: 10.1007/BF01815430. View

Hari Kumar K, Muthukrishnan J, Verma A, Modi K . Correlation between bone markers and bone mineral density in postmenopausal women with osteoporosis. Endocr Pract. 2009; 14(9):1102-7. DOI: 10.4158/EP.14.9.1102. View

Sachdeva A, Seth S, Khosla A, Sachdeva S . Study of some common biochemical bone turnover markers in postmenopausal women. Indian J Clin Biochem. 2012; 20(1):131-4. PMC: 3454147. DOI: 10.1007/BF02893058. View

Vs K, K P, Ramesh M, Venkatesan V . The association of serum osteocalcin with the bone mineral density in post menopausal women. J Clin Diagn Res. 2013; 7(5):814-6. PMC: 3681044. DOI: 10.7860/JCDR/2013/5370.2946. View

10.

Bhattarai T, Bhattacharya K, Chaudhuri P, Sengupta P . Correlation of common biochemical markers for bone turnover, serum calcium, and alkaline phosphatase in post-menopausal women. Malays J Med Sci. 2014; 21(1):58-61. PMC: 3952340. View

11.

Pirro M, Leli C, Fabbriciani G, Manfredelli M, Callarelli L, Bagaglia F . Association between circulating osteoprogenitor cell numbers and bone mineral density in postmenopausal osteoporosis. Osteoporos Int. 2009; 21(2):297-306. DOI: 10.1007/s00198-009-0968-0. View

12.

Stauber M, Muller R . Age-related changes in trabecular bone microstructures: global and local morphometry. Osteoporos Int. 2006; 17(4):616-26. DOI: 10.1007/s00198-005-0025-6. View

13.

Kanis J, Burlet N, Cooper C, Delmas P, Reginster J, Borgstrom F . European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2008; 19(4):399-428. PMC: 2613968. DOI: 10.1007/s00198-008-0560-z. View

14.

Indumati V, Patil V, Jailkhani R . Hospital based preliminary study on osteoporosis in postmenopausal women. Indian J Clin Biochem. 2012; 22(2):96-100. PMC: 3453808. DOI: 10.1007/BF02913323. View

15.

Salamat M, Salamat A, Abedi I, Janghorbani M . Relationship between Weight, Body Mass Index, and Bone Mineral Density in Men Referred for Dual-Energy X-Ray Absorptiometry Scan in Isfahan, Iran. J Osteoporos. 2013; 2013:205963. PMC: 3814102. DOI: 10.1155/2013/205963. View

16.

Moyad M . Preventing male osteoporosis: prevalence, risks, diagnosis and imaging tests. Urol Clin North Am. 2004; 31(2):321-30. DOI: 10.1016/j.ucl.2004.01.008. View

17.

Jagtap V, Ganu J, Nagane N . BMD and Serum Intact Osteocalcin in Postmenopausal Osteoporosis Women. Indian J Clin Biochem. 2012; 26(1):70-3. PMC: 3068775. DOI: 10.1007/s12291-010-0074-2. View

18.

Ghazi M, Mounach A, Nouijai A, Ghozlani I, Bennani L, Achemlal L . Performance of the osteoporosis risk assessment tool in Moroccan men. Clin Rheumatol. 2007; 26(12):2037-2041. DOI: 10.1007/s10067-007-0611-4. View